In a phase 2b trial, danicamtiv, a novel cardiac myosin activator, was well tolerated and associated with improved heart ...
Some cells, such as immune cells, are highly mobile—they constantly remodel their shape, migrate toward a wound that needs to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback